Mesenchymal stromal stem cells (MSCs) isolated from adult tissues offer tangible potential for regenerative medicine, given their feasibility for autologous transplantation. MSC research shows encouraging results in experimental stroke, amyotrophic lateral sclerosis, and neurotrauma models. However, further translational progress has been hampered by poor MSC graft survival, jeopardizing cellular and molecular bases for neural repair in vivo. We have devised an adult human bone marrow MSC (hMSC) delivery formula by investigating molecular events involving hMSCs incorporated in a uniquely designed poly(lactic-co-glycolic) acid scaffold, a clinically safe polymer, following inflammatory exposures in a dorsal root ganglion organotypic coculture system. Also, in rat T9-T10 hemisection spinal cord injury (SCI), we demonstrated that the tailored scaffolding maintained hMSC stemness, engraftment, and led to robust motosensory improvement, neuropathic pain and tissue damage mitigation, and myelin preservation. The scaffolded nontransdifferentiated hMSCs exerted multimodal effects of neurotrophism, angiogenesis, neurogenesis, antiautoimmunity, and antiinflammation. Hindlimb locomotion was restored by reestablished integrity of submidbrain circuits of serotonergic reticulospinal innervation at lumbar levels, the propriospinal projection network, neuromuscular junction, and central pattern generator, providing a platform for investigating molecular events underlying the repair impact of nondifferentiated hMSCs. Our approach enabled investigation of recovery neurobiology components for injured adult mammalian spinal cord that are different from those involved in normal neural function. The uncovered neural circuits and their molecular and cellular targets offer a biological underpinning for development of clinical rehabilitation therapies to treat disabilities and complications of SCI.
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spinal cord injury | recovery neurobiology | mesenchymal stromal stem cell | PLGA | locomotion R epair of neurotrauma, stroke, and neurodegenerative diseases remains an unmet medical demand because of their pathophysiological complexity and the limited spontaneous healing capacity of adult mammalian CNS. Human mesenchymal stromal stem cells (hMSCs) offer autologous transplantation feasibility (1) (2) (3) (4) and have been studied both experimentally and clinically for traumatic brain injury (TBI) and spinal cord injury (SCI) (5) (6) (7) (8) . Although MSCs possess homeostatic and proneurogenic activities (7, 9) , studies relying on neural transdifferentiation (i.e., putative differentiations of MSCs into neural cells without reentering the pluripotency phase) did not show long-term functional improvement in SCI models. The poor outcomes were attributed mainly to suboptimal survival of MSCs, leaving key therapeutic mechanisms undetermined (10) . We previously established a 3D cell delivery technology by seeding neural stem cells (NSCs) in biodegradable polymer scaffolds that significantly improved donor efficacy and enabled investigation of NSC repair mechanisms in the damaged CNS (11, 12) . In the present study, to test whether hMSCs might facilitate SCI recovery via multimodal actions of neural protection, plasticity, antiinflammation, and angiogenesis, rather than by transdifferentiation (7, 9, (11) (12) (13) (14) , we designed a unique microtexture poly(lactic-co-glycolic) acid (PLGA) scaffold that maintains the stemness of hMSCs and in an organotypic dorsal root ganglion (DRG) coculture system, determined that inflammatory agents would induce both antiinflammatory and proneurogenic actions of the scaffolded hMSCs. Moreover, the multifaceted effects of hMSCs in the scaffold-improved survival and stemness status were comprehensively studied in vivo to probe the cellular and circuitry components underlying the "recovery neurobiology" as a defined concept, of injured adult rat spinal cords.
Results
Characterization of Stem Cell Biology of hMSCs in Vitro. Following established protocols (3), we characterized the stemness status of hMSCs (MSCness) by the expression of representative markers and the capacity for phenotypic differentiation. The passage 6
Significance
We developed a platform technology to determine therapeutic mechanisms of human mesenchymal stromal stem cells (hMSCs) in a dorsal root ganglion coculture system and an intraspinal cord implantation model. The unique poly(lactic-co-glycolic) acid scaffolding augments hMSC stemness, engraftment, and function without neural transdifferentiation or mesenchymal lineage development, resulting in robust motosensory improvement, pain and tissue damage mitigation, and myelin preservation in adult rat spinal cord after injury. The scaffolded hMSC-derived neurotrophism, neurogenesis, angiogenesis, antiautoimmunity, and antiinflammation support the propriospinal network, neuromuscular junctions, and serotonergic reticulospinal reinnervation to activate the central pattern generator for restoring hindlimb locomotion. Our findings illuminate "recovery neurobiology"-i.e., the injured spinal cord may deploy polysynaptic neural circuits different from normal adulthood pathways for postinjury improvement.
(P6) hMSCs all expressed CD90 and CD105 markers (Fig. S1 A and B) and were capable of adipogenic, osteogenic, and chondrogenic differentiations as determined by Oil Red O (Fig. S1 C-F) , Alizarin Red S (Fig. S1 G-I) , and Alcian Blue staining ( Fig. S1 K and L), respectively. hMSCs of P9-P12 also demonstrated definitive adipogenic differentiation, although in reduced levels compared with that of P6 cells (Fig. S1C) . Additionally, real-time PCR was used to evaluate the adipogenic and osteogenic potencies of hMSCs by quantifying mRNA levels of adiponectin (Fig. S1D ) and alkaline phosphatase (Fig. S1J) , respectively. P8 cells showed significantly higher folds of mRNA expressions than P11 hMSCs undergoing differentiation. To test our hypothesis that homeostatic restoration of the host environment is a characteristic therapeutic impact of progenitor cells (9, 11) , P6-P12 and P5-P7 hMSCs were used for the present in vitro and in vivo experiments, respectively (3, 13, 15) .
Antiautoimmunity Actions of Scaffolded hMSCs Determined in Vitro.
In addition to expressing immunosuppressive factors (e.g., IL-10, TGF-β, prostaglandin E2), hMSCs, after inflammatory insults, increase the expression of indoleamine 2,3-dioxygenase (IDO) that catabolizes tryptophan into kynurenine, picolinic acid, and quinolinic acid, resulting in tryptophan depletion. The combinatorial outcomes drastically eliminate the activated T-cells through apoptosis (15, 16) . Although autoimmunity-triggered myelin loss has been reported to contribute to post-SCI disability (17) , whether the IDO-mediated immunosuppressive effect is beneficial for repair of injured spinal cord remained to be investigated (18) . We herein examined if IDO expression in hMSCs could be induced following direct exposure to the inflammatory mediator LPS, a trigger of autoimmune pathology, or to IFN-γ, a crucial factor for innate and adaptive immunity (19, 20) . We found that a period of 2-or 24-h exposure to LPS and INF-γ, respectively, resulted in high levels of IDO expression in the hMSCs ( Fig. 1A ; P < 0.01), compared with negative IDO immunoreactivity (IR) in the control cells. Similarly, the same regimens of LPS and INF-γ stimulation significantly augmented IDO production in the PLGA-scaffolded hMSCs ( Fig. 1B ; P < 0.01), validating the study design to examine the construct's immunomodulatory effect in injured spinal cord (21) .
Neurotherapeutic Mechanisms of PLGA-Scaffolded hMSCs Assessed in an Organotypic Coculture System. To counteract the paucity of well-characterized biomimetic models that permit effective in vitro screening of the complex mechanisms underlying adult stem cell-mediated neural benefits, we established an organotypic DRG and stem cell coculture assay by plating hMSCs around adult rat DRG explants (Materials and Methods). Such coculture settings induced neurite outgrowth from axonomized DRG neurons. The regenerating DRG neurites responded to hMSCs by changing their path to track and home toward hMSCs in closest proximity ( Fig. 1 C-E) , in contrast to neurite behavior in a DRG-alone preparation, where the less-regrown neurites manifested a nontargeted projection pattern (Fig. 1F) . We quantitatively compared the projection trajectory of neurite extension between the emergent segment and the terminal tip of the DRG after 48 h of coculture. The angle between the neurite directions at the two locations was taken as a measure of hMSCs' neurotropic potency. Whereas the control DRG (cultured alone) showed an average neurite trajectory angle of 48.15°without targeting preference, DRG cocultured with hMSCs showed a significantly increased average neurite path angle of 59.25°(P = 0.026 relative to controls, Student's t test), further diverging from the original trajectory to home toward hMSCs (Fig. 1G) .
We next investigated whether this DRG axonal extension/ homing was influenced by hMSC secretion of neurotropic and neurotrophic molecules. A unique type of PLGA scaffold with fine-tuned softness, smoothness, and pore size ranges (see details in Materials and Methods) was synthesized to maximize their protection of hMSC viability and stemness that are crucial for the functional multipotency of stem cells (9) (10) (11) (12) (13) . Survival of seeded hMSCs with characteristic spreading morphology was supported by the tailored scaffold (Fig. S2A) , and these hMSCs expressed BDNF and CD90 (Fig. S2 B and C) , indicating neurotrophic/tropic factor production and stemness maintenance (3) .
In the organotypic DRG coculture system, hMSCs scaffolded in PLGA or PLGA coated with hMSC medium alone as controls were placed alternately 2 mm away from either the proximal or distal axotomy side of each explanted DRG. After 48-h culture, the length of regenerated neurites in cocultures was measured (e.g., scaffolded hMSC side: Fig. 1H ; control side: Fig. 1I ). We observed a significant increase in the mean length (22% increase, P = 0.03; Fig. 1J , Upper) and in the maximum absolute distance of growth (45% increase, P = 0.03; Fig. 1J , Lower) of neurites on the DRG side next to the scaffolded hMSCs in comparison with the opposite side exposed to the control scaffold alone. Moreover, the group average number of regrowing neurites was markedly increased on the side of DRG next to the scaffolded hMSCs, relative to the control side exposed to the control scaffold (288% increase; 98 ± 22 vs. 34 ± 6 neurites, n = 6; P < 0.001, paired Student's t test). We also found that cocultured hMSCs, either scaffolded or not, expressed ciliary neurotrophic factor (CNTF) and BDNF, potent neurogenic and neuroprotective molecules ( Fig. 1 K and L) . The secretion of CNTF showed a pattern of dependence on target exposure, and BDNF secretion by hMSCs was significantly increased by the presence of dissected/injured DRG explants relative to the scaffold-only controls (P < 0.05; one-way ANOVA; Fig. 1I ). Overall, the data suggested that the active context/target-dependent biological responses (i.e., functional multipotency) of the scaffolded hMSCs may hold therapeutic potential for treating SCI (22) .
Evaluation of Antiinflammatory Effects of Scaffolded hMSCs in Vitro.
To simulate post-SCI inflammatory pathology (23) and evaluate the antiinflammatory potential of the scaffolded hMSCs, we challenged the organotypic DRG coculture system with LPS at 18 h after the assay initiation (20, 24) . Following a dose escalation of LPS (20 pg/mL to 1,000 ng/mL), a graded increase of TNF-α expression was triggered; above the LPS dose of 1,000 ng/mL, TNF-α production in the DRG plateaued (Fig. S3A ). DRG treated with 20 ng/mL LPS showed transient spikes of the proinflammatory cytokines TNF-α, IL-1β, and IL-6 expression, whereas coculture with PLGA-scaffolded hMSCs prevented these up-regulations ( Fig. S3 B-D) by decreasing the group mean levels of mRNA expressions of TNF-α, IL-6, and IL-1β by 62%, 72%, and 65%, respectively (Fig. S3 E-G) . The data demonstrated that we had established an in vitro cellular and molecular screening system for neural protection and repair events mediated by hMSCs (25) .
Motosensory Recovery After SCI Resulting from Scaffolded hMSC
Implantation in Vivo. To test our therapeutic device in lesioned spinal cord, the PLGA-scaffolded hMSC construct ( Fig. 2A ) was surgically implanted into the injury epicenter immediately following T9-T10 midline hemisection in female adult SpragueDawley rats (Fig. 2B) (11) . We monitored behavioral recovery, focusing on locomotion and evolution of neuropathic pain as clinically relevant outcome measures. The mean Basso, Beattie, and Bresnahan (BBB) score [an established open-field locomotion scale ranging from 0 (paralysis) to 21 (normal)] for the hindlimb ipsilateral to the injury site in the scaffolded hMSC treatment group was significantly higher throughout the 4 wk after SCI relative to control groups that received hMSCs alone, lesion alone, or scaffold alone ( Fig. 2C ; P < 0.05, repeatedmeasures ANOVA; n = 7/group). All rats were immunosuppressed with Prograf; Materials and Methods). In addition, an inclined plane assay was performed to test forelimb strength (i.e., general physical condition) in the upward-facing orientation and coordinated hindlimb motor function in the downward-facing orientation (11) . The scaffolded hMSC-treated group achieved significantly higher (downward facing) inclined plane mean angle than all control groups (Fig. 2D ), whereas no deficits in upwardfacing performance were observed in any group.
For changes in spinal reflexes, by 4 wk post-SCI, 71% of the scaffolded hMSC-treated rats displayed a normal reflex response to a brief pressure stimulus to the affected hindlimb, whereas none (0%) of the lesion-only controls showed normal reflexes (Fig. 2E) ; importantly, 57% of the scaffolded hMSC-treated rats were able to perform a normal contact righting reflex, in contrast to 0% of the lesion-only controls (Fig. 2F) . Thus, the scaffolded hMSC treatment was highly beneficial in recovering systemic (e.g., proprioception regarding contact righting) and local (e.g., brief pressure-induced spinal reflex) neural function in the SCI rats.
Sensory perturbations are common debilitating complications of clinical SCI. We evaluated the effects of scaffolded hMSC treatment on postinjury development of hypersensitivity, a type of sensory impairment associated with neuropathic pain conditions such as allodynia (26) . The hindlimb response to a quick nociceptive pinch (i.e., pain withdrawal reflex) demonstrated a marked reduction in incidence rate of hyperreflexia in the scaffolded hMSC-treated rats, compared with the controls (Fig. 2G ). For more detailed analyses, a barrage of sensory tests with standard 2-and 10-g Semmes-Weinstein filaments was performed weekly for each rat at approximately dermatomes T9-T10, as "at-level neuropathic pain," which is most frequently observed in clinical SCI (26) . At 4 wk post-SCI, rats treated with scaffolded hMSCs demonstrated a significantly lower prevalence of hypersensitivity, relative to non-hMSC-treated controls (Fig. 2H ), thus substantiating the therapeutic impact of scaffolded hMSC implantation for sensory disorders after SCI.
Histopathological Evaluation. Solvent blue and hematoxylin-stained spinal cord sections showed complete degradation of the PLGA scaffold in vivo ≥6 wk after SCI (Fig. 3A) . Based on assessment of tissue sparing in representative spinal cords of each group (i.e., tissue from SCI rats with BBB scores closest to the group mean; n = 4 per group), the scaffolded hMSC treatment showed the most extensive neuroprotection. In addition to an overall difference among groups (one-way ANOVA, P < 0.05), the mean lesion volume was 3.99 mm 3 in the scaffolded hMSC group compared with 8.76 mm 3 in the lesion-only control group (∼55% reduction in tissue loss; P < 0.05, Tukey's post hoc test; Fig. 3B ). We also quantified the white matter volume (Fig. 3C , Left) and ventral horn motor neuron number (Fig. 3D, Right) of the spinal cord tissue sampled at 1-mm intervals rostral and/or caudal to the injury epicenter of the same set of spinal cords (27, 28) . Relative to the controls, treatment with scaffolded hMSCs significantly spared white matter in tissue adjacent to the epicenter and enhanced the morphologic integrity of myelin determined by the solvent blue stain (27) (Fig. 3C , Center and Right, respectively); # , control vs. IFN-γ; n = 5; one-way ANOVA with Tukey's post hoc test). PLGA scaffolds showed yellow autofluorescence under dual channels. (C-E ) DRG in organotypic coculture grew neurites (GAP43+, green) that track toward nearby hMSCs (CD90+, red; arrows), compared with (F) a more radial neurite pattern in DRG cultured with scaffold only (G). There were significantly more angular neurite paths in DRG and scaffolded hMSC cocultures (59.25 ± 2.9°) relative to the DRG and scaffold-alone group (48.15 ± 4.1°; P = 0.026, Student's t test). Images showed different lengths of neurite outgrowth at the (H) distal and (I) proximal sites of axotomized DRG cocultured with PLGA-scaffolded hMSCs or scaffold alone, respectively. (J, Upper) The scaffolded hMSC and DRG cocultures had significant increases in mean total lengths when 3-20 neurites per DRG were averaged (*P = 0.032, n = 6, Mann-Whitney) and also (J, Lower) significantly increased the maximum absolute length of DRG neurite outgrow when 3-15 neurites per DRG were assessed (*P = 0.026, n = 6, Mann-Whitney). (K) Relative CNTF mRNA expression in scaffolded hMSCs was significantly elevated, as was (L) secretion of human BDNF (P < 0.05, one-way ANOVA) in the scaffolded hMSC + DRG coculture system. it also significantly protected motor neurons in spinal cord loci caudal to the lesion epicenter (i.e., −1 to −4 mm; Fig. 3D , Left). We did not observe any ectopic growth/colonization or tumorigenesis of hMSCs in the CNS or in those internal organs collected (lungs, kidneys, liver, and spleen).
Fate and Multimodal Effects of Scaffolded hMSCs in Vivo. hMSC engraftment was evaluated immunocytochemically (ICC) for expression of human CD90 (hCD90) or human heat shock protein 27 (hHSP27) in adjacent sections. We found that in contrast to controls treated with nonscaffolded hMSCs that showed no long-term survival of donor cells, ICC-positive cells for hHSP27 or hCD90 were both detected in the scaffolded hMSC-treated spinal cords, with no statistical difference in the mean number between the two ICC markers (Fig. 4A) , suggesting that the scored cells were of human origin with MSCness. The number of such hMSCs was highest at the lesion epicenter and sharply decreased within the surrounding 1-2 mm of host parenchyma in either direction, denoting the critical role of PLGA scaffolding for hMSC survival (11) and a strong tendency of hMSCs to remain close to the lesion epicenter. Surviving hMSCs at the injury site even at ∼6 wk postinjury was, on average, ≤2-5% of the cell number implanted. These hMSCs distributed slightly more in the rostral compared with the caudal side of the epicenter, a pattern similar to that reported previously for motor neuron sparing at T8 contusion epicenter (28) .
The functional multipotent status of hMSCs was ICC assessed by their expression of therapeutic mediators ( Fig. 1 and Figs. S2 and S3) (9, 11, 15) . Relative to the controls, BDNF expression was increased more than threefold (P < 0.05, one-way ANOVA with post hoc Student's t test) in spinal cords of rats bearing scaffolded hMSCs (Fig. 4B, Right) , elucidated in costaining for hHSP27 and DAPI (Fig. 4B) . Expression of IL-10 ( Fig. 4C , Right) was significantly higher in scaffolded hMSC-treated than in control spinal cords (P < 0.05, one-way ANOVA), largely in the remaining hMSCs, in contrast to the very limited number of host cells that showed IL-10 IR in the hMSC-alone group (Fig.  4C) . We next evaluated expression of collagens I, II, and IV by ICC to determine if phenotypic differentiation of hMSCs occurred in the spinal cords ≥6 wk after injury and implantation. The lack of detectable collagen presence, confirmed by confocal microscopy, suggested that hMSCs did not undergo terminal mesenchymal differentiation. Also, there were neither hMSCs-derived osteocytes determined by alkaline phosphatase (ALP) IR (Fig. 4D, Bottom) nor Oil Red O-stained adipocytes. Last, based on our established protocols (14), we found no hMSC-derived neurons, astrocytes, or oligodendrocytes [verified by MAB1273 (Chemicon) staining for human mitochondrial antigen].
To determine whether the neural repair outcomes were derived specifically from multimodal actions of hMSCs (25), we examined the immunoregulatory capability of hMSCs ( Fig. 1 A and B) to impede T-cells in the subacutely injured spinal cord (i.e., 7-10 d post-SCI; n = 3 per group). Despite administration of Prograf, CD3+ T cells were still present in the subacutely lesioned control tissue (21); PLGA-scaffolded hMSCs survived well and markedly increased expression of IDO (Fig. 4E) in the subacute SCI tissue, resulting in discernibly diminished presence of CD3+ T-cells in the white and gray matter at the epicenter (15, 25) (Fig. 4 F and G) and significantly mitigated invasion of iNOS-carrying mononuclear leukocytes (21, 25, 29) (Fig. 4H) , which likely helped to protect myelin integrity (Fig. 3C) . Compared with the lesion control tissue, Fig. 2 . Treatment designs and behavioral outcomes. Schematic presentations of (A) the in vitro hMSC seeding process for a PLGA scaffold and (B) design of the T9-T10 midline hemisection injury followed by implant insertion. Compared with three control groups, treatment with PLGA-scaffolded hMSCs significantly improved overall coordinated motor function as determined by (C) group mean BBB locomotion score of the hindlimb ipsilateral to injury and (D) inclined plane angle. Implantation of scaffolded hMSCs also significantly reduced occurrence of abnormal spinal reflexes in response to (E) pressure and (G) contact-triggered righting. Both (F) brief nociceptive pinch to the toe pads and (H) sensory tests at T9-T10 with standard 2-and 10-g Semmes-Weinstein filaments showed markedly higher hypersensitive responses in the controls relative to the scaffolded hMSC-treated rats (*, treated vs. lesion control, P < 0.05, Fisher's exact test). Data points (n = 7) represent average ± SEM or percent with normal (E-G) or abnormal (H) responses of each group, analyzed with repeatedmeasures ANOVA that showed an overall significant effect of treatment (P < 0.05). Symbols indicate that means are significantly different from those of the lesion-only (*), scaffold-only (#), and hMSCs-alone (^) control groups at the specified times after injury (Tukey's post hoc procedure or Student's t test).
scaffolded hMSCs with high IDO expression levels significantly polarized macrophage toward an arginase 1-positive M2 phenotype (Fig. 4H , Left and Center) inducible by IDO-generated tryptophan catabolites and considered to be beneficial for neural repair (30) , but reduced the number of activated microglia and macrophage (CD68+) in the subacute lesion epicenter (21) (Fig. 4H, Right) . Moreover, we noted that most donor hMSCs appeared to have died off by chronic postinjury stages. Thus, the tailored scaffolding approach to implanting hMSCs into adult spinal cord niche may have the combinatorial effect of preventing lineage differentiation, neural transdifferentiation, and tumor formation of MSCs.
Impediment of Chronic Inflammation. The inflammatory cascade paradoxically contributes to both postinjury neural damage and repair (23, 31) , so that subtly tuned antiinflammation capability has become a focus for treating CNS trauma (32) (33) (34) . Based on the antiinflammatory and antiautoimmunity effects of scaffolded hMSCs in vitro (Fig. 1 ) and in vivo (Fig. 4) , we assessed transverse sections at and adjacent to the lesion epicenter and found that GFAP, a marker of inflammation-triggered reactive astrogliosis (11), was lowest in spinal cords treated with scaffolded hMSCs (Fig. 5A ). In addition, IR for nitrotyrosine (Fig. 5B) , a "fingerprint" of protein nitration that indicates oxidative damage (29) , was also significantly reduced in the treated spinal cords. Furthermore, ICC staining for CD68 (Fig. 5C) , a marker of activated microglia and macrophages (35) , was significantly decreased in chronic SCI tissue following treatment with scaffolded hMSCs, compared with control groups. Relative to the lesionalone controls, the PLGA scaffold-only implant did not trigger discernibly worsened inflammatory responses in either subacutely or chronically injured spinal cords.
Neurobiological Mechanisms Underlying Post-SCI Recovery Following
Implantation of Scaffolded hMSCs. We first investigated the impact of donor cells on endogenous NSCs (36) in the host spinal cord on the inference that established roles of mesoderm-ectoderm interaction during development (37, 38) might partly apply in adult injury repair, and the known neural repair effects of activated endogenous NSCs (9, 14) . ICC analysis of doublecortin (DCX), a marker of migratory NSCs, revealed the presence of DCX+ NSCs that are normally absent in the intact adult mammalian spinal cord (39) . We found (Fig. 5D ) the number of DCX+ pixels in NSCs in the scaffolded hMSC-treated adult spinal cords 2 mm caudal to the lesion site to be significantly increased by ∼314%, compared with lesion-only or hMSC-only controls. Although activation by donor hMSCs of endogenous NSC proliferation, migration, and differentiation was previously described in the brain (36), the significant difference between the rats treated with scaffolded and nonscaffolded hMSCs suggests that a synthetic matrix tailored to enhance hMSC survival and stemness potently augmented the location-specific impact of hMSCs on adult spinal cord neurogenesis post-SCI, providing therapeutic benefits (9, 39). We also examined whether intraparenchymal angiogenesis, an important primary tissue repair mechanism that can be induced by MSCs (41) , was promoted by the scaffolded hMSC implant around the epicenter; a nearly fourfold increase in group mean IR against laminin, a primary angiogenic marker (41) , was detected by L9393, a pan antilaminin antibody, in the treated spinal cords relative to the controls (P < 0.05; Fig. 5E ). The laminin+ structures show morphologic features of blood vessels.
Because laminins, particularly those containing chains α2 and α5, are unique extracellular matrix protein components in the adult CNS neurogenic niche, and in addition to their effects on angiogenesis also promote neurite outgrowth (42), we investigated by ICC whether human laminin containing chains α2 and α5 was deposited by donor hMSCs around the epicenter. Indeed, (Fig. 5F , i and ii) these chains were secreted by scaffolded hMSCs around the implantation site in the subacutely injured spinal cord, and were present in the chronically injured tissue immediately caudal to the epicenter, forming (Fig. 5F, iii) an intertwined pattern of distribution with the sprouting serotonergic (5HT) neurites, indicating likely support for serotonergic reinnervation.
Our biotinylated dextran amine (BDA) anterograde tracing revealed no cross-epicenter regeneration of corticospinal tract (CST) axons in all spinal cord funiculi involved (e.g., Fig. 6 A and C showed the dorsal funiculus data) for all study groups. There was no evidence of rubrospinal tract (RST) regrowth beyond the lesion site, as determined (Fig. S4) by ICC of vGluT2, a primary marker of RST terminals (43) . We thereby used a novel "peripheral-central" and "bottom-up" tracing strategy to elucidate the neural pathways responsible for the observed recovery of locomotion in the treated rats. We specifically investigated whether the rodent central pattern generator (CPG) for hindlimb locomotion might be partially activated by submidbrain inputs (40, 44) ; this was done by injecting different retrograde tracers [i.e., DiI, Fast Blue (FB), and Fluoro-Gold (FG)] into the cervical, thoracic, abdominal, and hindlimb muscles and performing 5HT ICC (Fig. 6 A and B ; Materials and Methods) (40, 43, 44) . We also immunochemically evaluated the distribution and quantity of synaptophysin, a pansynaptic vesicle protein and vGluT1, the primary proprioceptive terminal glutamate transporter interacting with propriospinal interneurons (PSNs) in Rexed's Laminae (RL) IV-VIII and RL IX motor neurons (45) . We found that compared with the lesion-only controls, the spinal cords treated with scaffolded hMSCs had a significantly stronger mean IR for synaptophysin around the ventral horn motor neurons at the cervical and thoracic segments with higher signal levels of DiI and FB (Fig. 6D) , respectively, and of FG ( Fig. 6E ; see statistics in Fig. 6F ). The treated spinal cords also contained more 5HT+ fibers and vGluT1-positive buttons in the upper lumbar segments, suggesting improved plasticity of the propriospinal projection system that interacts actively with the 5HT+ reticulospinal fibers in the CPG region (Fig. 6G ) (46) (47) (48) (49) . We also observed that at T10-T11, the engrafted and still undifferentiated hMSCs [i.e., stromal cell antigen 1 (STRO-1)+ cells] significantly augmented surrounding host cells' expression of connexin 43 (Cx43), the main gap junction-forming protein unit between neural cells, NSCs and inflammatory cells (32, 50) , compared with controls (Fig. 6H) . Notably, scaffolded hMSC-treated spinal cords, relative to controls, showed nearly normal T6-T8 dorsal horn innervation of primary proprioceptive fibers (Fig. 6I ) and DRG neuronal integrity (Fig.  6J) as assessed by intramuscular retrograde tracers, and reduced degeneration of hindlimb neuromuscular junctions (NMJs: labeled by α-bungarotoxin; Fig. 6K ). Clearly, the scaffolded hMSC-treated SCI rats showed an overall enhancement of the proprioceptive network and NMJ integrity, which might work together with improved descending serotonergic facilitation to reanimate CPG for locomotion recovery.
Discussion
We have developed an hMSC-delivering platform technology by seeding hMSCs in a uniquely designed PLGA matrix to improve donor cell survival in a nondifferentiated state and in a localized engraftment that fosters implant-host interaction in vivo. Developed concurrently is a neurotrauma-relevant DRG coculture system for in vitro screening of multiple neurotherapeutic effects of stem cells. Our synthetic matrix supports hMSC survival, stemness, and function, avoiding phenotypic differentiation, ectopic donor cell engraftment, and tumorigenesis in lesioned adult rat E) . Moreover, h-laminin secretion from hMSCs (CD90+; green) near the epicenter in the subacutely injured spinal cord was detected (F, i: h-laminin α2 chain; ii: h-laminin α5 chain). Last, h-laminin deposition persisted chronically to ≥6 wk after injury in the same region (F, iii: h-laminin α2 chain) and showed intimate interactions with 5-HT+ axonal fibers, suggesting its promotion of serotonergic reinnervation (F, iii). spinal cord. The scaffolded hMSCs implanted at a T9-T10 hemitransection site robustly restore locomotor function and prevent neuropathic pain by mitigating T-cell-mediated demyelination and augmenting M2 macrophage polarization, by providing BDNF, CNTF, and IL-10 cytokines, serotonergic neurite sprouting, and morphologic integrity of thoracolumbar synapses, and by promoting angiogenesis, endogenous neurogenesis, and gap junction formation. Notably, these biological effects were exerted by hMSCs in the progenitor state, without mesenchymal lineage differentiation or neural transdifferentiation. Thereby, hMSCs may provide their therapeutic impacts mainly through functional multipotency events, conducive to post-SCI coordination of four components essential for hindlimb locomotor recovery: (i) serotonergic reticulospinal reinnervation caudal to the lesion; (ii) propriospinal projection network plasticity; (iii) NMJ integrity; and (iv) CPG reactivation (40, (43) (44) (45) . In regard to CST axonal regrowth as the frequently pursued central regenerative goal in treating SCI, these outcomes collectively introduce a different theoretical and experimental platform to investigate stem cell-based therapy that sets forth an interactive set of recovery neurobiology mechanisms for lesioned adult mammalian spinal cord. Although the T9-T10 lesion paradigm we used does not directly model spinal cord contusion, the most common SCI seen clinically, it offers the special opportunity to investigate precisely lesion scale, secondary injury, donor cell fate, neuroprotection, neurite outgrowth, and intraspinal cord pathway plasticity (11, 29, 46) . Targeting each of the multiple pathophysiological mechanisms underlying SCI individually has to date yielded a high number of proposals, indicating their inadequacy and occasional mutual contradictions (48) . We and others have proposed that the complexity and heterogeneity of SCI pathology necessitates development of multimodal integrated mechanistic and therapeutic regimens (11, 46, 48) . We now consider the scaffolded hMSCs to represent an effective strategy based on the multiple therapeutic mechanisms observed in the present study, especially the cooperative effects of tissue sparing, serotonergic axonal sprouting, and propriospinal plasticity. Previously, implantation of a PLGA scaffold by itself that had different texture and composition tailored to enhance spinal cord healing significantly improved function in the same rat SCI model (11) . By contrast, the matrix of the present formulation designed to maintain MSCness, when used by itself as an implant, was not sufficiently efficacious for post-SCI hindlimb recovery. Our data suggest that a correctly formulated synthetic matrix is crucial for realization of the intended biological effects without triggering side effects. The porous and flexible attributes of the current PLGA scaffold are essential for maintaining the basic stemness biology of hMSCs, avoiding unwanted mesenchymal differentiation. Compared with other types of polymers, PLGA offers reliable chemical engineering properties that can be adapted to optimize stem cell seeding and fate control (11) . It has been reported lately that substrate stiffness could regulate the stemness level of progenitor cells (51) . hMSCs under our delivery regimen exercised their homeostatic function while undifferentiated, and later died off, probably by apoptosis, because no necrosis-triggered inflammatory signs were spotted. This process may describe a desirable cell fate for nonneural progenitor cells serving for SCI treatment. The donor cells interacted with host cells to produce molecules that ameliorate local pathology. There was up-regulation of IDO, M2 polarization, endogenous neurogenesis, and gap junction formation, accompanied by down-regulation of proinflammatory cytokines, T-cells, and M1 macrophages (22, 23, 32, 39, 50) , all in site-specific actions realized through tailored PLGA scaffolding of hMSCs and in a manner essentially unachievable for repairing open wounds by hMSC-conditioned medium or nonscaffolded cells. Hence, the notion of implanting stem cells pre-or postdifferentiated to a neural lineage may be working at cross-purposes to the developmental imperatives of the multipotent cells in certain cases, particularly for systemic repair of complex organs such as the spinal cord and brain (25, 32, 33) . Our results suggest that scaffolded hMSCs may be adaptable for implantation directly into the contused spinal cord of patients in the subacute phase after injury when autoimmune and inflammatory insults peak (4, 33, 41, 48) .
Traditional belief has attributed functional recovery observed after SCI in rodents primarily to the regrowth of CST and/or RST axons. Nevertheless, following thoracic lesion of descending motor pathways, neuroplasticity also occurs more caudally in the PSN network and lumbar CPG, a semiautonomous neural circuit for locomotion (45, 49) . Studies examining "spinalized" cats or humans with incomplete SCI have demonstrated that motor cues, such as weight-suspended treadmill training or treadmill walk, can reanimate the CPG and its reengagement of arm swing, respectively (52, 53) . Previously, a combinatorial application of direct electrical stimulation or administration of 5-HT receptor agonists enabled locomotion in spinalized rodents with dual spinal cord hemisections by igniting the PSN network for CPG activation through relaying CST signals (44) . The present data, however, show that scaffolded delivery of hMSCs restored locomotor function in adult rats with T9-10 hemisection without promoting CST and RST regeneration across the injury epicenter or neural transdifferentiation of hMSCs. Our deductive analysis reveals that functional improvement of the affected hindlimb was likely supported by CPG activation via a submidbrain circuitry that is driven by treatment-enhanced reciprocal communication among the serotonergic reticulospinal pathway, PSN, and the neuromuscular system secured by NMJ preservation. We observed significantly increased IR of vGluT1 and synaptophysin expression and augmented presence of serotonergic fibers in RL IV-VIII around the epicenter and in RL IX of lumbar segments in the treated spinal cord relative to the controls. It was shown that after unilateral pyramidal tract section, proprioceptive fibers could sprout into the denervated motoneuron region as an evidence of maladaptive plasticity (54) . By contrast, our results demonstrate that the enhanced PSN network, together with improved serotonergic reinnervation and preserved NMJs resulting from scaffolded hMSC implantation, exemplify beneficial plastic adaptations; this, combined with better preserved dorsal horn proprioceptive innervation, may serve as a pivotal mechanism to reactivate CPG and impede neuropathic pain following SCI. We are currently analyzing selective lesion data generated by targeted transgenic models in mice to verify the essential role of each specific neural component in recovering locomotion after SCI.
In conclusion, our findings corroborate the newly emerging observation that adult mammalian spinal cord contains inherent circuits that may be therapeutically recruited and modulated to restore function posttrauma (8, 49, 53, 55) . These results collectively suggest it is plausible that direct axonal connections from motor cortex neurons to spinal cord are not essential for reestablishment of basic locomotion after mammalian SCI (55) (56) (57) . Our results help define recovery neurobiology: the lesioned adult CNS may use neural circuits not identical to those deployed under normal physiological conditions for functional improvement. Therefore, SCI repair studies, in addition to pursuing regeneration of the CST and RST, should investigate recovery requirements that are specific for restoring targeted function. Tailored polymer scaffolding for hMSC delivery offers new opportunities for adult stem cell-based approaches to understanding and treating neurotrauma and perhaps other types of neural degeneration (58) .
Materials and Methods
Experimental group size in the in vivo study was set at n = 7 per group based on power analysis of the outcome measure data of a previous study (28) . All rats survived the entire study and were tested behaviorally at day 1 and then weekly after injury through ≥4 wk after injury. Remaining information is detailed in SI Materials and Methods.
All surgical procedures were performed in strict compliance with the Laboratory Animal Welfare Act and the Guide for the Care of Use of Laboratory Animals (59) after review and approval by the Institutional Animal Care and Use Committee of the VA Boston Healthcare System or Harvard Medical School.
